Pharmaceutical mergers and megamergers stifle innovation
RUBY WALLAU FOR STAT
Pharmaceutical mergers and megamergers, like the AbbVie and Allergan deal, may be good for business, bit it isn't good for innovation — or consumers.
¿Cómo sabemos que el cambio climático es real?
Hace 6 horas
.png)
No hay comentarios:
Publicar un comentario